Rchr
J-GLOBAL ID:200901039873041635   Update date: Jul. 16, 2024

Mizukawa Yoshiko

ミズカワ ヨシコ | Mizukawa Yoshiko
Affiliation and department:
Research field  (1): Dermatology
Research keywords  (2): 皮膚免疫 ,  allergy
Research theme for competitive and other funds  (27):
  • 2019 - 2022 Risk of progression to autoimmune disease in severe drug eruption patients: identification of risk factors and trial for risk factor-guided stratification
  • 2017 - 2021 Clinical and immunological analysis of onset of dipeptidyl peptidase-4 inhibitor associated bullous pemphigoid
  • 2012 - 2015 The role of patrolling monocytes in inflammary dermatoses in which herpesviruses can trigger
  • 2011 - 2013 analysis for the role of the neuropeptides in the IgE-dependent allergic responses
  • 2009 - 2011 Analysis of factors that regulate effector T cell and regulatory T cell recruitment to the skin
Show all
Papers (44):
  • Yoshiko Mizukawa, Natsumi Hama, Fumi Miyagawa, Hayato Takahashi, Youichi Ogawa, Maiko Kurata, Hideo Asada, Riichiro Abe, Tetsuo Shiohara. Drug-Induced Hypersensitivity Syndrome/Drug Reaction With Eosinophilia and Systemic Symptoms: Predictive Score and Outcomes. The journal of allergy and clinical immunology. In practice. 2023
  • Natsumi Hama, Yuma Sunaga, Hirotaka Ochiai, Akatsuki Kokaze, Hideaki Watanabe, Michiko Kurosawa, Hiroaki Azukizawa, Hideo Asada, Yuko Watanabe, Yukie Yamaguchi, et al. Development and Validation of a Novel Score to Predict Mortality in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: CRISTEN. The journal of allergy and clinical immunology. In practice. 2023
  • Hirohiko Sueki, Yuko Watanabe, Seiko Sugiyama, Yoshiko Mizukawa. Drug allergy and non-HIV immune reconstitution inflammatory syndrome. Allergology international : official journal of the Japanese Society of Allergology. 2022. 71. 2. 185-192
  • Yoshiko Mizukawa, Yumi Aoyama, Hayato Takahashi, Ryo Takahashi, Tetsuo Shiohara. Risk of Progression to Autoimmune Disease in Severe Drug Eruption: Risk Factors and the Factor-Guided Stratification. The Journal of investigative dermatology. 2022. 142. 3 Pt B. 960-968
  • 渡邉 裕子, 池田 信昭, 山口 由衣, 水川 良子, 大山 学, 宮川 史, 浅田 秀夫, 渡辺 秀晃, 末木 博彦, 井川 健, et al. 免疫チェックポイント阻害薬による皮膚障害の解析. 日本皮膚科学会雑誌. 2021. 131. 8. 1841-1850
more...
MISC (64):
  • T. Shiohara, Y. Mizukawa. Comment on ‘Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19’: involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID-19. Journal of the European Academy of Dermatology and Venereology. 2021. 35. 2. e98-e100
  • Yoshiko Mizukawa, Yohei Sato, Manabu Ohyama, Tetsuo Shiohara. Restoration of sweating disturbance in atopic dermatitis treated with dupilumab. Journal of Dermatological Science. 2020. 100. 1. 79-81
  • Tetsuo Shiohara, Yoshiko Mizukawa. Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019. Allergology International. 2019. 68. 3. 301-308
  • Tetsuo Shiohara, Yoshiko Mizukawa, Yurie Shimoda-Komatsu, Yumi Aoyama. Sweat is a most efficient natural moisturizer providing protective immunity at points of allergen entry. Allergology International. 2018. 67. 4. 442-447
  • 小野 蘭, 田代 康哉, 安藤 はるか, 渡辺 秀晃, 末木 博彦, 水川 良子, 大山 学, 井川 健, 小豆澤 宏明, 浅田 秀夫, et al. 細胞増殖に作用する分子標的薬による皮膚障害の検討. 日本皮膚科学会雑誌. 2018. 128. 6. 1373-1373
more...
Professional career (1):
  • (BLANK)
Association Membership(s) (3):
日本臨床皮膚科医学会 ,  日本研究皮膚科学会 ,  日本皮膚科学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page